Cargando…

Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis

INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was u...

Descripción completa

Detalles Bibliográficos
Autores principales: Arismendi, Maria, Giraud, Matthieu, Ruzehaji, Nadira, Dieudé, Philippe, Koumakis, Eugenie, Ruiz, Barbara, Airo, Paolo, Cusi, Daniele, Matucci-Cerinic, Marco, Salvi, Erika, Cuomo, Giovanna, Hachulla, Eric, Diot, Elisabeth, Caramaschi, Paola, Riccieri, Valeria, Avouac, Jérôme, Kayser, Cristiane, Allanore, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422604/
https://www.ncbi.nlm.nih.gov/pubmed/25880423
http://dx.doi.org/10.1186/s13075-015-0572-y
_version_ 1782370080022069248
author Arismendi, Maria
Giraud, Matthieu
Ruzehaji, Nadira
Dieudé, Philippe
Koumakis, Eugenie
Ruiz, Barbara
Airo, Paolo
Cusi, Daniele
Matucci-Cerinic, Marco
Salvi, Erika
Cuomo, Giovanna
Hachulla, Eric
Diot, Elisabeth
Caramaschi, Paola
Riccieri, Valeria
Avouac, Jérôme
Kayser, Cristiane
Allanore, Yannick
author_facet Arismendi, Maria
Giraud, Matthieu
Ruzehaji, Nadira
Dieudé, Philippe
Koumakis, Eugenie
Ruiz, Barbara
Airo, Paolo
Cusi, Daniele
Matucci-Cerinic, Marco
Salvi, Erika
Cuomo, Giovanna
Hachulla, Eric
Diot, Elisabeth
Caramaschi, Paola
Riccieri, Valeria
Avouac, Jérôme
Kayser, Cristiane
Allanore, Yannick
author_sort Arismendi, Maria
collection PubMed
description INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was undertaken to investigate whether single-nucleotide polymorphisms (SNPs) identified by a large genome-wide association study (GWAS) in PBC might contribute to SSc susceptibility. METHODS: Sixteen PBC susceptibility SNPs were genotyped in a total of 1,616 patients with SSc and 3,621 healthy controls from two European populations (France and Italy). RESULTS: We observed an association between PLCL2 rs1372072 (odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.12 to 1.33, P(adj) = 7.22 × 10(−5)), nuclear factor-kappa-B (NF-κB) rs7665090 (OR = 1.15, 95% CI 1.06 to 1.25, P(adj) = 0.01), and IRF8 rs11117432 (OR = 0.75, 95% CI 0.67 to 0.86, P(adj) = 2.49 × 10(−4)) with SSc susceptibility. Furthermore, phenotype stratification showed an association between rs1372072 and rs11117432 with the limited cutaneous subgroup (lcSSc) (P(adj) = 4.45 × 10(−4) and P(adj) = 0.001), whereas rs7665090 was associated with the diffuse cutaneous subtype (dcSSc) (P(adj) = 0.003). Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associated with increased interferon-gamma (IFN-γ) expression (P = 0.03) in patients with SSc but decreased type I IFN (IFIT1) expression in patients and controls (P = 0.02). In addition, we found an epistatic interaction between NF-κB and IRF8 (OR = 0.56, 95% CI 0.00 to 0.74, P = 4 × 10(−4)) which in turn revealed that the IRF8 protective effect is dependent on the presence of the NF-κB susceptibility allele. CONCLUSIONS: An analysis of pleiotropic genes identified two new susceptibility genes for SSc (NF-κB and PLCL2) and confirmed the IRF8 locus. Furthermore, the IRF8 variant influenced the IFN signature, and we found an interaction between IRF8 and NF-κB gene variants that might play a role in SSc susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0572-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4422604
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44226042015-05-07 Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis Arismendi, Maria Giraud, Matthieu Ruzehaji, Nadira Dieudé, Philippe Koumakis, Eugenie Ruiz, Barbara Airo, Paolo Cusi, Daniele Matucci-Cerinic, Marco Salvi, Erika Cuomo, Giovanna Hachulla, Eric Diot, Elisabeth Caramaschi, Paola Riccieri, Valeria Avouac, Jérôme Kayser, Cristiane Allanore, Yannick Arthritis Res Ther Research Article INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was undertaken to investigate whether single-nucleotide polymorphisms (SNPs) identified by a large genome-wide association study (GWAS) in PBC might contribute to SSc susceptibility. METHODS: Sixteen PBC susceptibility SNPs were genotyped in a total of 1,616 patients with SSc and 3,621 healthy controls from two European populations (France and Italy). RESULTS: We observed an association between PLCL2 rs1372072 (odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.12 to 1.33, P(adj) = 7.22 × 10(−5)), nuclear factor-kappa-B (NF-κB) rs7665090 (OR = 1.15, 95% CI 1.06 to 1.25, P(adj) = 0.01), and IRF8 rs11117432 (OR = 0.75, 95% CI 0.67 to 0.86, P(adj) = 2.49 × 10(−4)) with SSc susceptibility. Furthermore, phenotype stratification showed an association between rs1372072 and rs11117432 with the limited cutaneous subgroup (lcSSc) (P(adj) = 4.45 × 10(−4) and P(adj) = 0.001), whereas rs7665090 was associated with the diffuse cutaneous subtype (dcSSc) (P(adj) = 0.003). Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associated with increased interferon-gamma (IFN-γ) expression (P = 0.03) in patients with SSc but decreased type I IFN (IFIT1) expression in patients and controls (P = 0.02). In addition, we found an epistatic interaction between NF-κB and IRF8 (OR = 0.56, 95% CI 0.00 to 0.74, P = 4 × 10(−4)) which in turn revealed that the IRF8 protective effect is dependent on the presence of the NF-κB susceptibility allele. CONCLUSIONS: An analysis of pleiotropic genes identified two new susceptibility genes for SSc (NF-κB and PLCL2) and confirmed the IRF8 locus. Furthermore, the IRF8 variant influenced the IFN signature, and we found an interaction between IRF8 and NF-κB gene variants that might play a role in SSc susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0572-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-21 2015 /pmc/articles/PMC4422604/ /pubmed/25880423 http://dx.doi.org/10.1186/s13075-015-0572-y Text en © Arismendi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Arismendi, Maria
Giraud, Matthieu
Ruzehaji, Nadira
Dieudé, Philippe
Koumakis, Eugenie
Ruiz, Barbara
Airo, Paolo
Cusi, Daniele
Matucci-Cerinic, Marco
Salvi, Erika
Cuomo, Giovanna
Hachulla, Eric
Diot, Elisabeth
Caramaschi, Paola
Riccieri, Valeria
Avouac, Jérôme
Kayser, Cristiane
Allanore, Yannick
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title_full Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title_fullStr Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title_full_unstemmed Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title_short Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
title_sort identification of nf-κb and plcl2 as new susceptibility genes and highlights on a potential role of irf8 through interferon signature modulation in systemic sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422604/
https://www.ncbi.nlm.nih.gov/pubmed/25880423
http://dx.doi.org/10.1186/s13075-015-0572-y
work_keys_str_mv AT arismendimaria identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT giraudmatthieu identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT ruzehajinadira identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT dieudephilippe identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT koumakiseugenie identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT ruizbarbara identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT airopaolo identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT cusidaniele identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT matuccicerinicmarco identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT salvierika identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT cuomogiovanna identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT hachullaeric identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT diotelisabeth identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT caramaschipaola identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT riccierivaleria identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT avouacjerome identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT kaysercristiane identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis
AT allanoreyannick identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis